Effects of 2-chloro-2′-deoxyadenosine on the cell cycle in the human leukemia EHEB cell line

Nucleosides, Nucleotides and Nucleic Acids

Volumn 23, Issue 8-9, 2004, Pages 1425-1429

  Cardoen, S ^a   Van Den Neste, E ^a,b   Smal, C ^a   Rosier, J F ^c   Ferrant, A ^b   Van Den Berghe, G ^a   Bontemps, F ^a  

^a DE DUVE INSTITUTE   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c Centre Hospitalier Jolimont Lobbes   (Belgium)

Author keywords

2 Chloro 2 deoxyadenosine; B CLL; CdA resistance; Cell cycle; G1 S transition; PRb

Indexed keywords

CLADRIBINE; DEOXYCYTIDINE KINASE; PROTEIN P21; PROTEIN P53;

CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONFERENCE PAPER; CONTROLLED STUDY; DNA SYNTHESIS; DRUG MECHANISM; DRUG METABOLISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL; PHASE TRANSITION; PROTEIN INDUCTION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; BROMODEOXYURIDINE; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLADRIBINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DEOXYCYTIDINE KINASE; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FLOW CYTOMETRY; G1 PHASE; HUMANS; INHIBITORY CONCENTRATION 50; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MODELS, BIOLOGICAL; PHOSPHORYLATION; S PHASE; TIME FACTORS;

EID: 10344250453     PISSN: 15257770     EISSN: None     Source Type: Journal    
DOI: 10.1081/NCN-200027653     Document Type: Conference Paper

References (8)

1. Huang, M.C.; Ashmum, R.A.; Avery, T.L.; Kuehl, M.; Blackley, R.L. Effects of cytotoxicity of 2-chloro-2′-deoxyadenosine and 2-bromo-2′- deoxyadenosine on cell growth, clonogenicity, DNA synthesis, and cell cycle kinetics. Cancer Res. 1986, 46, 2362-2368.
2. Cardoen, S.; Van Den Neste, E.; Smal, C.; Rosier, J.F.; Delacauw, A.; Ferrant, A.; Van den Berghe, G.; Bontemps, F. Resistance to 2-chloro-2′- deoxyadenosine of the human B-cell leukemia cell line EHEB. Clin. Cancer Res. 2001, 7, 3559-3566.
3. analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo. Proc. Natl. Acad. Sci. U. S. A. 1980, 77, 6865-6869.
4. Achanta, G.; Pelicano, H.; Feng, L.; Plunkett, W.; Huang, P. Interaction of p53 and DNA-PK in response to nucleoside analogues: potential role as a sensor complex for DNA damage. Cancer Res. 2001, 16, 8723-8729.
5. Shi, Z.; Azuma, A.; Sampath, D.; Li, Y.X.; Huang, P.; Plunkett, W. S-phase arrest by nucleoside analogues and abrogation of survival without cell cycle progression by 7-hydroxystaurosporine. Cancer Res. 2001, 61, 1065-1072.
6. Gartenhaus, R.B.; Wang, P.; Hoffman, M.; Janson, D.; Rai, K.R. The induction of p53 and WAF/CIP1 in chronic lymphocytic leukemia cells treated with 2-chlorodeoxyadenosine. J. Mol. Med. 1996, 74, 143-147.
7. WAF1 expression on sensitivity of cancer cells to cladribine. Biochem. Pharmacol. 2003, 65, 121-129.
8. Sampath, D.; Shi, Z.; Plunkett, W. Inhibition of cyclin-dependant kinase 2 by the Chk1-Cdc25A pathway during the S-phase checkpoint activated by fludarabine: dysregulation by 7-hydroxystaurosporine. Mol. Pharmacol. 2002, 62, 680-688.